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Abstract: Toxoplasma gondii (T. gondii) is a cosmopolitan protozoan parasite that infects all warm-
blooded species including humans. The definitive hosts of T. gondii are felid vertebrates including
the domestic cat. Domestic cats shed oocysts for approximately two weeks in their feces after the
primary infection. It has been shown that feline immunodeficiency virus (FIV) positive cats have
a higher prevalence of and a higher titer of antibodies to T. gondii than those of FIV-negative cats.
The main purposes of this study were to determine FIV prevalence and to investigate the oocysts
shedding in FIV-positive and FIV-negative feral cats on St. Kitts. Fecal samples were collected from
feral cats while their FIV statues were determined using a commercial SNAP kit. Total fecal DNA
of each cat was tested for the presence of T. gondii DNA using a polymerase chain reaction (PCR)
consistently detecting one genome equivalent. A FIV-positive status was detected in 18 of 105 (17.1%,
95% confidence interval (CI): 9.9%−24.3%) feral cats sampled. Furthermore, males were three times
more likely to be FIV positive than females (p = 0.017) with an odds ratio of 3.93 (95% CI: 1.20–12.89).
Adults were found to have at least twice the prevalence of FIV compared to cats younger than one
year of age (p = 0.056) with an odds ratio of 3.07 (95% CI: 0.94–10.00). Toxoplasma gondii DNA was
not detected in the feces of any of the 18 FIV-positive (95% CI: 0%−0.18%) and 87 FIV-negative
cats (95% CI: 0%−0.04%). A follow-up study with a much bigger sample size is needed to prove or
disprove the hypothesis that FIV-positive cats have a higher prevalence of shedding T. gondii oocysts
than FIV-negative cats.
Keywords: Toxoplasma gondii; oocyst shedding; domestic cat; feral cat; feline immunodeficiency virus;
feline leukemia virus
1. Introduction
Toxoplasma gondii, a cosmopolitan protozoan, requires an intermediate host and a
definitive host in its life cycle. The intermediate host covers all warm-blooded vertebrates
including humans whereas the definitive host is narrowly limited to the domestic cat
(Felis catus) and other felids. A definitive host may shed oocysts in its feces for approx-
imately two weeks upon the primary infection. Specifically it releases the oocysts in its
feces for 3–10 days, ≥18 days and ≥13 days respectively, for being infected by ingestion
of tissue cysts with bradyzoites, oocysts or tachyzoites [1]. Upon infection by tissue cysts
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with bradyzoites, a domestic cat starts oocyst shedding as early as four days post infection
(PI) and ends at Day 16 PI with a major peak between the day 5 and day 7 PI [2–4].
Oocyst shedding by cats and the resultant environmental contamination with oocysts
play an important role in the high prevalence of T. gondii among various intermediate hosts
worldwide because one of the major routes of infection for the intermediate host is by
oral ingestion of infective oocysts [5,6]. It is widely accepted that a definitive host sheds
oocysts for approximately two weeks when it is initially infected thereafter it no longer
sheds oocysts upon secondary (subsequent) infection due to a long-lasting immunity to
prevent oocyst shedding. Limited laboratory data have also suggested that oocyst shedding
occurs after secondary infection with the same or different strains of the primary infection
although with a much lower number of oocysts shed [4,7]. Furthermore, it has been
shown in the laboratory that cats with primary T. gondii infection that have stopped oocyst
shedding start to re-shed oocysts again starting 20–21 days after immunosuppression that is
induced by daily parenteral administration of dexamethasone (1 mg/kg/day) for 30 days.
This re-shedding lasts 9–10 days [8]. However, whether a definitive host with immunity
as a result of a prior exposure starts to re-shed oocysts once its immunity is compromised
needs to be tested and confirmed in feline populations. Feline immunodeficiency virus
(FIV) eventually causes an inability of its host’s immune system to mount an effective
cell-mediated immune response, resulting in marked immune dysfunction with severe
and progressive respiratory and intestinal disease in its host [9]. It has been showed that
FIV-positive urban stray cats have a higher prevalence and higher titer of antibodies to
T. gondii compared to FIV-negative cats [10,11]. It has been found that 84.9% of domestic
cats on St. Kitts have antibodies to T. gondii [12] and 16.5% of cats on St Kitts are FIV
positive [13]. It is likely that FIV infection in a domestic cat changes the dynamics of its
oocyst shedding with T. gondii infection rendering it to re-shed oocysts and/or shed oocysts
for an extended period of time, leading to an increase in T. gondii prevalence in feces among
FIV-positive cats in comparison with FIV-negative ones. The main objective of the current
study was to investigate fecal oocyst shedding in the FIV-positive versus FIV-negative feral
cats. An additional aim was to give an update of FIV prevalence on St. Kitts as previous
studies had existed.
2. Materials and Methods
2.1. Ethical Approval
Animal use of the study was approved by the Institutional Animal Care and Use
Committee (IACUC) of Ross University School of Veterinary Medicine with the approval
IACUC number (15-1-001).
2.2. Sample Size
The samples size was calculated using the following formula: sample size
n = [Z1−α/22 × p × (1 − p)]/d2 as previously described [14]. For the current study,
we assumed the prevalence of 2.5% and 5% of T. gondii DNA in the feces of FIV-negative
and FIV-positive cats, respectively. We wanted to calculate sample size with the preci-
sion/absolute error of 10% (d = 0.1) and at type I error of 5% (Z1−α/2 = 1.96). Therefore,
for FIV-negative cats: n = (1.962 × 0.025 × 0.975)/0.12 = 9 samples; for FIV-positive cats:
n = (1.962 × 0.05 × 0.95)/0.12 = 18 samples.
2.3. Data and Sample Collection
Feral cats were caught between September 2014 and July 2015 on St. Kitts. They were
all included in a trap–neuter–return program entitled the ‘Feral Cat Project’ (FCP). The
FCP was started years ago and has been continuously carried out by the Ross University
Veterinary Clinic (RUVC) in order to manage and control the population of the feral cats
on the island. Feral cats were caught at 15 locations at Basseterre and adjacent areas
including new road, Texaco Gas station, Matingly, Lime Kiln, Half Moon Bay, Calypso
Bay, Bird Rock, Depay Bay, food center, Camps, Horizons Villa, Basseterre and West Farms.
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They were brought to RUVC where their sex and age were determined prior to neutering.
Their ages were determined as young if less than one year of age or adult if more than
one year of age based on dentition, body weight and stature. Upon anesthesia blood
and feces were collected from each cat prior to their neutering and the FIV-positive cats
were euthanized. Euthanasia was performed while the cat was under general anesthesia
by injecting a barbituric acid derivative intravenously that is, pentobarbital as a single
agent at 120 mg/kg. Death was confirmed by a veterinarian by absence of a corneal
reflex, apnea and heartbeat. Euthanasia was strictly limited to a period of two years to
study the long-term effect of removal of FIV-positive cats on general FIV prevalence on
St. Kitts, which constitutes a MSc thesis. All cats in the FCP were tested for FIV antibodies
using a commercially available patient-side test (SNAP FIV/FeLV Combo Test, IDEXX
Laboratories, Westbrook, ME, USA) as per the manufacturer’s instruction. Colon flush
was collected after each cat was infused 3 mL veterinary saline (Abbott Laboratory, Abbott
Park, IL, USA) using a lubricated Kendall Feeding Tube and Urethral Catheter (Covidien,
LLC., Mansfield, MA, USA) connected to a 5 mL syringe. Approximately one gram of feces
was taken from the anus using a gloved finger in the case of very firm stool. The fecal
samples were frozen immediately and kept at −80 ◦C prior to DNA extraction.
2.4. Detection of Toxoplasma gondii
Total DNA was individually extracted from each feces using QIAamp DNA Stool Kit
(QIAGEN, Germantown, MD, USA) according to the manufacturer’s instructions. DNA
quality and quantity were monitored with the Tecan Infinite M200 Pro (Tecan, Mannedorf,
Switzerland) or NanoPhotometer (Implen, Westlake Village, CA, USA). All DNAs were kept
at −20 ◦C until use. To detect the DNA of T. gondii polymerase chain reaction (PCR) was per-
formed to target the 529-base pair (bp) repeat element of T. gondii using the primer pair Tox-9F
(5′AGGAGAGATATCGGGACTGTAG3′) and Tox-11R (5′GCGTCGTCTCGTCTAGATCG3′)
with an expected amplicon of 163 bp. The method was chosen due to its high sensitivity,
that is, it has been reported quantitative PCR (qPCR) amplification of the element consis-
tently detects one genome equivalent (80 fg DNA) per sample and is still positive in 7 out
of 30 samples when the level of DNA is as low as 0.8 fg DNA [15,16]. All PCR was per-
formed using HotStart Taq Plus 2×Master Mix (QIAGEN) with 0.5 µM final concentration
of each forward and reverse primer as previously described [17]. Briefly, 9.8 µL of each
fecal DNA extracts was used as a template in 20 µL PCR mix. PCR was carried out in a
thermal cycler (Mastercycler Nexus Gradient, Eppendorf, Hauppauge, NY, USA) with the
following parameters: initial denaturing at 95 ◦C 2 min, 45 cycles of 95 ◦C 30 s, 58 ◦C 30 s
and 72 ◦C 1 min followed by a final extension at 72 ◦C for 10 min. DNA of the RH strain
(genotype I) of T. gondii and molecular grade water were used as positive and negative
controls, respectively. The amount of positive control DNA used in each PCR was 27.4 fg.
The PCR amplicons were detected by electrophoresis of the all mix on a 1.5% agarose gel
using a 100-bp ladder (Invitrogen, Carlsbad, CA, USA) as a size marker. Positive samples
were repeatedly tested and were deemed false positive provided that the second PCR
was negative.
3. Results
3.1. FIV Prevalence of Feral Cats on St. Kitts
Between September 2014 and July 2015 a total of 105 feral cats were sampled. The
overall prevalence of FIV was 17.1% (18/105). More specifically FIV prevalence was 25.5%
(14/55) for males and 8.0% (4/50) for females. The odds ratio (OR) for being male was 3.93
(95% confidence interval (CI): 1.20–12.89). FIV prevalence was 11.5% for the cats younger
than 1 year old (6/53) and 28.8% for the cats were over 1 year old (8/28). OR for being the
latter was 3.07 (95% CI: 0.94–10.00) (Table 1).
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Table 1. Age, sex and the status of feline immunodeficiency virus (FIV) of feral cats tested in the study.
Age # FIV+ FIV– Total Prevalence (%) 95% CI Odds Ratio 95% CI
<1 year 6 46 52 11.5 2.8–20.2
≥1 year 8 20 28 28.8 12.0–45.6 3.06 0.94–10.00
ND 4 21 25 16.0 1.6–30.4
Total 18 87 105 17.1 9.9–24.3
Sex *
Male 14 41 55 25.5 14.7–37.0 3.93 1.20–12.89
Female 4 46 50 8.0 0.5–15.5
Total 18 87 105 17.1 9.9–24.3
ND: Not determined. CI: confidence interval. #: χ2 statistic is 3.6573 between < 1 and ≥ 1 year group; p = 0.056.
*: χ2 statistic is 5.6176; p = 0.018.
All 105 feral cats were tested negative for feline leukemia virus (FeLV) antigens, which
is consistent with earlier reports that St. Kitts cats are FeLV free [18,19] and will not be
further discussed.
3.2. Failure to Detect T. gondii DNA in Feral Cats’ Feces
Among 18 FIV-positive and 87 FIV-negative feral cats, none of their feces were found
to be T. gondii positive by PCR. The 95% CI of T. gondii prevalence for the FIV-positive
and -negative cats were 0−0.18% and 0−0.04%, respectively. The 95% CI for the overall
prevalence of T. gondii of the feral cat population included in the current study ignoring
their FIV status was 0.00−0.03%.
4. Discussion
The purpose of the current study was to detect oocyst shedding among feral cats on St.
Kitts by taking advantage of the high FIV prevalence among them [13]. Neither the 18 FIV-
positive nor the 87 FIV-negative cats on St. Kitts that were tested for T. gondii using the
highly sensitive PCR amplification of the 529-bp repeat element were found to be positive
for shedding this protozoan. It has been reported that this molecular technique is capable
of constantly detecting one genome equivalent, that is, 80 fg DNA and approximately
one-quarter times with one hundredth genome equivalent of T. gondii [15,16]. We used one-
third genome equivalent DNA as positive controls and it worked consistently. Therefore, it
is of high confidence to state that the estimate prevalence of oocyst shedding of T. gondii
in feral cats on St. Kitts, no matter whether FIV-positive or FIV-negative is close to zero
(95% CI: 0.00−0.03%). It is worth pointing out that not all the stools during a cat’s window
of oocyst shedding would have contained T. gondii oocysts because the oocyst release is
not continuous. Furthermore, an immunocompetent cat sheds oocysts for approximately
only two weeks during the primary infection in its entire life [1–4]. This combination of a
narrow oocyst shedding window and discontinuous oocyst shedding greatly reduce the
probability to get a positive fecal sample in an infected cat.
In general, oocyst shedding is low among domestic cats. In a survey of feral cat feces
by fecal flotation with a detection limit of 250 oocysts/g of feces, one of 78 samples collected
on Prince Edward Island, Canada was found to contain T. gondii oocysts [20]. In Sao Paula
State, Brazil, the prevalence of oocysts among client owned domestic cats was 1.3% (3/237)
determined by microscopy and bioassay [21]. In the Morro Bay area of California, it was
0.9% (3/326). Specifically, it was 1.3% (2/153) in client owned cats and 0.9% (1/107) in
feral cats [22]. Among 61,224 fecal samples of client owned pet cats submitted to IDEXX
for diagnosis 84 (0.14%) were found to be positive with T. gondii DNA by PCR. In a similar
survey, 0.11% (26/24,106) of fecal samples of client owned domestic cats from Germany,
Austria, France and Switzerland were positive [23,24]. It should also be cautious that not
all positive results of PCR for detecting T. gondii DNA in cat feces is from oocysts. Those
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cats who ingested a T. gondii-infected prey were always found to be PCR positive one day
after ingestion, this positive finding may even extend to the following two days [25].
Between September 2014 and July 2015, an overall FIV prevalence of 17.1% was found
among the feral cats at 15 different locations near Basseterre, St. Kitts. Earlier reports of FIV
prevalence on the same island showed 15.2% in 2006–2007, 13.9% in 2009 and 36.4% in 2010
in feral cat populations [18,19]. The much higher prevalence in 2010 might be due to small
sample size of only 11 cats [19]. The FIV prevalence among feral cats on St. Kitts between
2006 and 2015 apparently maintained a constant level of approximately 15% despite of
continuous effort of FCP to minimize mating and aggression by neutering. The current
reported rate was similar to that of feral cat population in Germany [26]. It is much higher
than that of feral cat populations in many regions such as Ethiopia [27], Portugal [28,29],
Korea [30], Florida [31,32] Ottawa, Canada [33], Prince Edward Island, Canada [20,34],
Texas [35], Hawaii [36], UK [37], Belgium [11] and is lower than that of feral cat populations
in UK [38], Egypt [39], Australia [40] and Grenada, West Indies [41] (Table 2). Furthermore,
the prevalence was much higher in male cats compared to female cats with an OR 3.93
(95% CI: 1.20–12.89, Table 1). This is similar to what has been previously observed in
the domestic cat. In South Australia, de-sexed males had a much lower prevalence than
intact males. Both intact and de-sexed male had a higher prevalence than female cats.
More specifically the prevalence in the de-sexed and intact males between the age of 5 and
9 years old was 17% and 27%, respectively while the prevalence difference in the groups
between the age of 9 and 13 years old was 16% and 35%, respectively. In contrast, the
prevalence for the same age group of de-sexed and intact female was 7% and 5%, 10% and
0%, respectively [42]. What causes male cats to have a higher prevalence than female cats
remains to be determined in the feral population. It is hypothesized that the major mode
of FIV transmission among the domestic cat is by the aggressive behavior such as biting
between male cats [42]. However, it is also worth noting that no difference was detected
between sexes for FIV prevalence in feral cats in the Barley Park Farm, UK [38]. In addition,
the FIV prevalence of the feral cats one year old or older was at least double that of ones
less than one year old with an OR 3.06 (95% CI: 0.94–10.00, Table 1). This may be due to
behavioral and/or biological difference between kittens and adults.
One drawback of the study was a limited sample size with a possible type II error. Al-
though sample sizes of both FIV-negative and FIV-positive feral cats met minimal estimates
no cats were detected positive for T. gondii. This is surprising with the high seropreva-
lence of T. gondii in the feral cat population and in other domestic animals on St. Kitts.
Three quarters of the feral cats carried antibodies to this parasite during two cross-sectional
survey studies carried out in 2005–2006 by a modified agglutination test. In addition,
16–23% of pigs, sheep and goats were PCR positive for the parasite’s DNA in their heart
tissues [12,41,44]. Another limitation of this study was the lack of titers of antibodies to
FIV. Not all FIV-positive cats are immunocompromised. FIV-positive animals might take
years to develop disease. It is plausible that the lack of oocytes shedding in FIV-positive
cats could be because they have not reached an immunosuppressed status yet. A bigger
samples size with their antibody titers determined would have certainly increased our
chances of detecting T. gondii DNA in feral cats. The third limitation was omitting fecal
flotation to detect T. gondii oocysts, which was due to not enough fecal material collected
from all cats for such an analysis. Nevertheless, PCR employed here consistently detected
T. gondii DNA when only approximately one-third of a genome DNA equivalent was used
in positive controls. Lastly, the study subjects were not tested for antibodies to T. gondii, so
their infection status were unknown. Therefore, it is impossible to discern whether a nega-
tive PCR for T. gondii DNA in feces is due to lack of oocyst shedding in a T. gondii-infected
cat or lack of infection in an uninfected animal.
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Table 2. The prevalence of feline immunodeficiency virus (FIV) among feral cats in different geographic regions.
Region Cats Examined FIV + Cats Prevalence (%) Year References
Europe
Ghent, Belgium 346 39 11.3 1998–2000 [11]





















Addis Ababa, Ethiopia 41 0 0.0 [27]
Cairo, Egypt 174 59 33.9 2008–2009 [39]
Asia
Seoul, Korea 66 2 3.0 2013 [30]
North America
Key Largo, Florida 3.3 1999–2013 [31]
Northern Florida 553 29 5.2 1999–2000 [32]
College Station, Texas 155 10 6.5 1998–2000 [35]
Mauna Kea, Hawaii 68 6 8.8 2002–2004 [36]
Ottawa, Canada 20 1 5.0 2000 [33]









Merida, Mexico 227 2.5 [43]
St. Kitts, West Indies 99 15 15.2 2006–2007 [18]
St. Kitts, West Indies 72 10 13.9 2009 [18]
St. Kitts, West Indies 11 4 36.4 2010 [19]
St. Kitts, West Indies 105 18 17.1 2014–2015 This study
Grenada, West Indies 101 22 21.8 2004–2007 [41]
Oceania
Sydney, Australia 68 15 22.1 2003–2004 [40]
Finally, it is worthy of concisely discussing mortality in FIV infected cats with an
active or reactivated T. gondii infection. Two fatal cases of myelitis in cats with FIV and
T. gondii co-infection have been reported. The first case was a 10-year-old cat with pro-
gressive paralysis and a postmortem diagnosis was made with ultrastructural analysis
and immunohistochemistry [45]. The second case was a 10-year-old cat suffering from
reactivated toxoplasmosis, resulting in lameness of the right thoracic limb and bilateral
pelvic limb paresis. Nevertheless, the cat had been vaccinated with FIV vaccine within
the past 12 months [46]. Furthermore, it had been found under laboratory conditions that
clinically normal cats carrying active FIV infections suffered from catastrophic general
toxoplasmosis upon paratenic infection with T. gondii tachyzoites [47]. Consequently, it is
plausible that FIV and T. gondii co-infected cats are removed from the feral cat population,
which diminishes our capacity to detect the parasite.
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5. Conclusions
The sampled feral cats on St. Kitts, irrespective of their FIV status were not detected
shedding T. gondii oocysts as determined by a highly sensitive PCR, which was apparently
hindered by a combination of narrow window of and discontinuous oocyst shedding of
infected cats. In St. Kitts, male feral cats were three times more likely to be FIV positive
than females and adults were two times more likely to be FIV positive compared to young
cats. The zoonotic risk of exposure to T. gondii through feral cats, irrespective of their FIV
status could not be accurately determined in the current study. A further study with a
much larger sample size is warranted to test the hypothesis that FIV-positive cats have a
higher prevalence than FIV-negative ones in shedding T. gondii oocysts.
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